대동맥류 시장 : 세계 업계 분석, 규모, 점유율, 성장, 동향, 예측(2031년) - 유형별, 치료별, 제품별, 최종사용자별, 지역별
Aortic Aneurysm Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
상품코드:1420353
리서치사:Fairfield Market Research
발행일:2024년 01월
페이지 정보:영문 296 Pages
라이선스 & 가격 (부가세 별도)
한글목차
세계의 대동맥류 시장 규모는 2024년에 39억 1,000만 달러에 달할 것으로 보이며, 2024-2031년의 예측 기간 중 현저한 성장을 나타낼 것으로 예측되며 96억 1,000만 달러에 달할 것으로 전망됩니다.
죽상동맥경화증의 이환율 증가와 그에 따른 리스크가 시장 성장의 주요 촉진요인이 되고 있습니다. 세계의 고령자 인구의 증가는 환자 수에 크게 기여하고 있습니다. 미국 보건복지부는 고령자 인구의 대폭적인 증가를 예측하고 있으며, 2040년에는 808억 명, 2060년에는 947억 명에 달할 것으로 예측하고 있습니다. 흡연은 대동맥류 발증의 중대한 위험 요인이며, 세계의 담배의 보급이 시장의 성장에 기여하고 있습니다. 저침습 시술에 대한 수요의 증가와 유리한 의료 상환 정책이 시장의 확대를 한층 더 촉진하고 있습니다.
대동맥류와 치료 비용에 대한 대중의 낮은 인식이 시장 성장을 저해하는 요인으로 작용하고 있습니다. 장골 천공, 스텐트 협착, 내막 누출, 말단 긴장 등 대동맥류 치료와 관련된 합병증은 시장 성장에 걸림돌이 되고 있습니다. 선진국에서는 기존 수술에서 EVAR과 같은 최소침습 수술로의 대체가 늦어지고 있는 것도 주목할 만한 시장 과제입니다.
세계의 대동맥류 시장에 대해 조사했으며, 시장의 개요와 유형별, 치료별, 제품별, 최종사용자별, 지역별 동향 및 시장에 참여하는 기업의 경쟁 동향 등을 제공하고 있습니다.
목차
제1장 주요 요약
제2장 시장 개요
시장의 정의와 세분화
시장 역학
밸류체인 분석
Porter's Five Forces 분석
COVID-19의 영향 분석
우크라이나와 러시아의 분쟁의 영향
경제 개요
PESTLE 분석
제3장 세계의 대동맥류 시장 전망, 2018-2031년
세계의 대동맥류 시장 전망, 유형별, 금액(10억 달러), 2018-2031년
세계의 대동맥류 시장 전망, 치료별, 금액(10억 달러), 2018-2031년
세계의 대동맥류 시장 전망, 제품별, 금액(10억 달러), 2018-2031년
세계의 대동맥류 시장 전망, 최종사용자별, 금액(10억 달러), 2018-2031년
세계의 대동맥류 시장 전망, 지역별, 금액(10억 달러), 2018-2031년
제4장 북미의 대동맥류 시장 전망, 2018-2031년
제5장 유럽의 대동맥류 시장 전망, 2018-2031년
제6장 아시아태평양의 대동맥류 시장 전망, 2018-2031년
제7장 라틴아메리카의 대동맥류 시장 전망, 2018-2031년
제8장 중동 및 아프리카의 대동맥류 시장 전망, 2018-2031년
제9장 경쟁 구도
제품별과 치료별 히트맵
제조업체별과 치료별 히트맵
기업의 시장 점유율 분석, 2023년
경쟁 대시보드
기업 개요
Medtronic
Endologix LLC
Gore Medical
MicroPort Scientific Corporation
Cook
JOTEC
Cardinal Health
Terumo Corporation
Lombard Medical
AbbVie Inc.
제10장 부록
KSA
영문 목차
영문목차
The global aortic aneurysm market, valued at US$ 3.91 Billion in 2024, is set to exhibit remarkable growth during the forecast period from 2024 to 2031. This substantial growth trajectory aims to accumulate a market value of US$ 9.61 Billion by 2031.
Factors Driving Market Growth:
The growth of the aortic aneurysm market can be attributed to several pivotal factors:
Increasing Prevalence of Atherosclerosis: The rising incidence of atherosclerosis and its associated risks have become major drivers of market growth.
Rising Geriatric Population: The expanding elderly population globally is contributing significantly to the patient pool. The U.S. Department of Health and Human Services predicts a substantial increase in the elderly population, reaching 80.8 Billion by 2040 and 94.7 Billion by 2060.
Smoking-Related Risk: Smoking is a significant risk factor for developing aortic aneurysms, and the global prevalence of tobacco use is contributing to the market growth.
Minimally Invasive Procedures: The increasing demand for minimally invasive procedures and favorable health reimbursement policies are further augmenting market expansion.
Challenges Faced by the Aortic Aneurysm Market:
Despite the positive growth prospects, the market faces certain challenges, including-
Lack of Awareness: Limited awareness among the general public about aortic aneurysms and the cost associated with their treatment is hampering market growth.
Complications: Complications related to aortic aneurysm treatment, such as iliac perforation, stent stenosis, endoleaks, and end tension, pose challenges to the market.
Traditional vs. Minimally Invasive Procedures: The slow replacement of traditional surgical procedures by minimally invasive surgeries, such as EVAR, in advanced countries is a noteworthy market challenge.
Regional Insights:
North America: Rapid technological advancements, a shift toward minimally invasive procedures, and the implementation of health screening programs have positioned North America as a prominent market, accounting for 47% of the aortic aneurysm market share in 2022.
Europe: Europe's significant market share can be attributed to technological advancements and the high prevalence of atherosclerosis. National organizations, such as the National Health Service (NHS), are actively working to reduce aortic aneurysm incidences.
Asia Pacific: The Asia Pacific region is expected to witness substantial growth due to a rising aging population, an increased prevalence of cardiovascular diseases, and growing disposable income. The presence of a sizable aging population is favoring market expansion.
Competitive Analysis:
Key players in the aortic aneurysm market are actively involved in research, product development, and collaborations to enhance their market presence. Some notable developments include:
In March 2021, Cook Medical, Inc. received FDA breakthrough device designation for Zenith Fenestrated+ Endovascular Graft (ZFEN+), used in treating intravascular AA.
Endologix LLC is expanding its geographical presence by selling EVAR products in multiple countries, including the U.S., Canada, New Zealand, South Korea, and Europe.
Key Companies Profiled:
Medtronic
Endologix LLC
Gore Medical
MicroPort Scientific Corporation
Cook
JOTEC
Cardinal Health
Terumo Corporation
Lombard Medical
AbbVie Inc.
Key Segments Profiled in the Aortic Aneurysm Industry Survey
Aortic Aneurysm by Type
Aortic Aneurysm by Thoracic Aortic Aneurysm (TAA)
Aortic Aneurysm by Abdominal Aortic Aneurysm (AAA)
Aortic Aneurysm Treatment
Aortic Aneurysm by Open Surgical Repair (OSR)
Aortic Aneurysm by Endovascular Aneurysm Repair (EVAR)
Aortic Aneurysm Product
Aortic Aneurysm by Stent Grafts
Aortic Aneurysm by Catheters
Aortic Aneurysm End User
Aortic Aneurysm by Hospitals
Aortic Aneurysm by Ambulatory Surgery Centers
Aortic Aneurysm by Clinics
Aortic Aneurysm Region
North America Aortic Aneurysm Market
Latin America Aortic Aneurysm Market
Europe Aortic Aneurysm Market
Asia Pacific Aortic Aneurysm Market
Middle East & Africa Aortic Aneurysm Market
Table of Contents
1. Executive Summary
1.1. Global Aortic Aneurysm Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2023
1.5. Analyst Recommendations
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter's Five Forces Analysis
2.5. COVID-19 Impact Analysis
2.5.1. Supply
2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
2.7.1. World Economic Projections
2.8. PESTLE Analysis
3. Global Aortic Aneurysm Market Outlook, 2018 - 2031
3.1. Global Aortic Aneurysm Market Outlook, by Type, Value (US$ Bn), 2018 - 2031
3.1.1. Key Highlights
3.1.1.1. Aortic Aneurysm by Thoracic Aortic Aneurysm (TAA)
3.1.1.2. Aortic Aneurysm by Abdominal Aortic Aneurysm (AAA)
3.2. Global Aortic Aneurysm Market Outlook, by Treatment, Value (US$ Bn), 2018 - 2031
3.2.1. Key Highlights
3.2.1.1. Aortic Aneurysm by Open Surgical Repair (OSR)
3.2.1.2. Aortic Aneurysm by Endovascular Aneurysm Repair (EVAR)
3.3. Global Aortic Aneurysm Market Outlook, by Product, Value (US$ Bn), 2018 - 2031
3.3.1. Key Highlights
3.3.1.1. Aortic Aneurysm by Stent Grafts
3.3.1.2. Aortic Aneurysm by Catheters
3.4. Global Aortic Aneurysm Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
3.4.1. Key Highlights
3.4.1.1. Aortic Aneurysm by Hospitals
3.4.1.2. Aortic Aneurysm by Ambulatory Surgery Centers
3.4.1.3. Aortic Aneurysm by Clinics
3.5. Global Aortic Aneurysm Market Outlook, by Region, Value (US$ Bn), 2018 - 2031
3.5.1. Key Highlights
3.5.1.1. North America
3.5.1.2. Europe
3.5.1.3. Asia Pacific
3.5.1.4. Latin America
3.5.1.5. Middle East & Africa
4. North America Aortic Aneurysm Market Outlook, 2018 - 2031
4.1. North America Aortic Aneurysm Market Outlook, by Type, Value (US$ Bn), 2018 - 2031
4.1.1. Key Highlights
4.1.1.1. Aortic Aneurysm by Thoracic Aortic Aneurysm (TAA)
4.1.1.2. Aortic Aneurysm by Abdominal Aortic Aneurysm (AAA)
4.2. North America Aortic Aneurysm Market Outlook, by Treatment, Value (US$ Bn), 2018 - 2031
4.2.1. Key Highlights
4.2.1.1. Aortic Aneurysm by Open Surgical Repair (OSR)
4.2.1.2. Aortic Aneurysm by Endovascular Aneurysm Repair (EVAR)
4.3. North America Aortic Aneurysm Market Outlook, by Product, Value (US$ Bn), 2018 - 2031
4.3.1. Key Highlights
4.3.1.1. Aortic Aneurysm by Stent Grafts
4.3.1.2. Aortic Aneurysm by Catheters
4.4. North America Aortic Aneurysm Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
4.4.1. Key Highlights
4.4.1.1. Aortic Aneurysm by Hospitals
4.4.1.2. Aortic Aneurysm by Ambulatory Surgery Centers
4.4.1.3. Aortic Aneurysm by Clinics
4.5. North America Aortic Aneurysm Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
4.5.1. Key Highlights
4.5.1.1. U.S. Aortic Aneurysm Market by Type, Value (US$ Bn), 2018 - 2031
4.5.1.2. U.S. Aortic Aneurysm Market Treatment, Value (US$ Bn), 2018 - 2031
4.5.1.3. U.S. Aortic Aneurysm Market Product, Value (US$ Bn), 2018 - 2031
4.5.1.4. U.S. Aortic Aneurysm Market End User, Value (US$ Bn), 2018 - 2031
4.5.1.5. Canada Aortic Aneurysm Market by Type, Value (US$ Bn), 2018 - 2031
